Go Pro

Foresite Capital Management Vi LLC Top Holdings and 13F Report (2026)

About Foresite Capital Management Vi LLC

Investment Activity

  • Foresite Capital Management Vi LLC has $642.58 million in total holdings as of June 30, 2026.
  • Foresite Capital Management Vi LLC owns shares of 23 different stocks, but just 10 companies or ETFs make up 80% of its holdings.
  • Approximately 27.50% of the portfolio was purchased this quarter.
  • About 9.36% of the portfolio was sold this quarter.
  • This quarter, Foresite Capital Management Vi LLC has purchased 17 new stocks and bought additional shares in 6 stocks.
  • Foresite Capital Management Vi LLC sold shares of 1 stock and completely divested from 2 stocks this quarter.

Largest Holdings

CG Oncology, Inc.
$168,358,233
ALUMIS INC.
$119,529,434
Seaport Therapeutics, Inc.
$38,651,196

Largest New Holdings this Quarter

81221K108 - Seaport Therapeutics, Inc.
$38,651,196 Holding
698955101 - Parabilis Medicines, Inc.
$27,343,834 Holding
07373V105 - Beam Therapeutics
$11,325,600 Holding
04272N102 - ArriVent BioPharma, Inc.
$10,468,586 Holding
05153U107 - Aura Biosciences
$9,466,671 Holding

Largest Purchases this Quarter

Seaport Therapeutics, Inc.
1,779,521 shares (about $38.65M)
Parabilis Medicines, Inc.
999,044 shares (about $27.34M)
Celldex Therapeutics
563,800 shares (about $20.98M)
GH Research
625,001 shares (about $16.80M)
Jade Biosciences, Inc.
566,667 shares (about $12.59M)

Largest Sales this Quarter

Minerva Neurosciences
1,016 shares (about $5.64K)

Sector Allocation Over Time

Map of 500 Largest Holdings ofForesite Capital Management Vi LLC

 
 
Selling
 
 
Neutral
 
 
Buying
Issuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSector
CG Oncology, Inc.
$168,358,233$10,522,505 â–²6.7%2,369,57426.2%COM
ALUMIS INC.
$119,529,4340.0%4,247,67018.6%COM
Seaport Therapeutics, Inc.
$38,651,196$38,651,196 â–²New Holding1,779,5216.0%COM
Denali Therapeutics Inc. stock logo
DNLI
Denali Therapeutics
$35,924,950$4,804,496 â–²15.4%1,396,7715.6%Healthcare
Celldex Therapeutics, Inc. stock logo
CLDX
Celldex Therapeutics
$32,734,121$20,978,998 â–²178.5%879,7135.1%Healthcare
Agios Pharmaceuticals, Inc. stock logo
AGIO
Agios Pharmaceuticals
$29,131,350$9,648,600 â–²49.5%785,0004.5%Healthcare
Corvus Pharmaceuticals, Inc. stock logo
CRVS
Corvus Pharmaceuticals
$27,358,6210.0%1,831,2334.3%Healthcare
Parabilis Medicines, Inc.
$27,343,834$27,343,834 â–²New Holding999,0444.3%COM
GH Research PLC stock logo
GHRS
GH Research
$25,280,452$16,800,027 â–²198.1%940,4933.9%Healthcare
Jade Biosciences, Inc.
$19,701,741$12,591,341 â–²177.1%886,6673.1%COM
Hinge Health, Inc.
$18,293,2000.0%220,4002.8%CL A
Kymera Therapeutics, Inc. stock logo
KYMR
Kymera Therapeutics
$16,779,8900.0%146,3322.6%Healthcare
AtaiBeckley Inc.
$14,492,5000.0%2,750,0002.3%COM
Verastem, Inc. stock logo
VSTM
Verastem
$12,020,1300.0%3,146,6311.9%Healthcare
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$11,325,600$11,325,600 â–²New Holding330,0001.8%Healthcare
Minerva Neurosciences, Inc stock logo
NERV
Minerva Neurosciences
$11,019,991$5,639 â–¼-0.1%1,985,5841.7%Healthcare
ArriVent BioPharma, Inc.
$10,468,586$10,468,586 â–²New Holding301,3411.6%COM
Aura Biosciences, Inc. stock logo
AURA
Aura Biosciences
$9,466,671$9,466,671 â–²New Holding1,333,3341.5%Healthcare
Crinetics Pharmaceuticals, Inc. stock logo
CRNX
Crinetics Pharmaceuticals
$7,933,4140.0%212,0101.2%Healthcare
Research Alliance Corp III
$3,210,000$3,210,000 â–²New Holding300,0000.5%CL A
Zura Bio Limited stock logo
ZURA
Zura Bio
$2,655,0000.0%450,0000.4%Healthcare
Kailera Therapeutics, Inc.
$826,125$826,125 â–²New Holding37,5000.1%COM
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$70,946$70,946 â–²New Holding9700.0%Healthcare
Centessa Pharmaceuticals PLC Sponsored ADR stock logo
CNTA
Centessa Pharmaceuticals
$0$54,178,835 â–¼-100.0%00.0%Healthcare
OnKure Therapeutics, Inc.
$0$5,985,542 â–¼-100.0%00.0%COM CL A

Showing largest 100 holdings. View all holdings.
SEC Filings and Trading Data